In children with chronic kidney disease (CKD), optimal control of bone and mineral
homeostasis is essential, not only for the prevention of debilitating skeletal complications …

Elevated serum phosphate is a risk factor for vascular calcification and cardiovascular
events in kidney disease as well as in the general population. Elevated phosphate levels …

OBJECTIVE: The objective of this study was to determine the prevalence of phosphorus-
containing food additives in best-selling processed grocery products and to compare the …

Objectives: This review explores the challenges and solutions in educating patients with
chronic kidney disease (CKD) to lower serum phosphorus while avoiding protein …

In recent years, the imbalance in phosphate homeostasis in patients with end-stage renal
disease (ESRD) has been the subject of much research. It appears that, while …

Prevention and correction of hyperphosphatemia is a major goal of chronic kidney disease–
mineral and bone disorder (CKD–MBD) management, achievable through avoidance of a …

Background Chronic kidney disease–mineral and bone disorders (CKD–MBD) are important
complications of CKD5D patients that are associated with mortality. Methods COSMOS is a …

Elevated serum phosphorus levels are common in patients with chronic kidney disease and
are associated with heart and vascular disease, conditions that in turn are associated with …

As kidney disease progresses, phosphorus retention also increases, and phosphate binders
are used to treat hyperphosphatemia. Clinicians prescribe phosphate binders thinking that …

Hyperphosphatemia is an important determinant of morbidity and mortality in patients with
chronic kidney disease (CKD). Patients with CKD are advised to consume a low phosphate …